Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Other Operating Expenses (2016)

Arrowhead Pharmaceuticals (ARWR) has disclosed Other Operating Expenses for 10 consecutive years, with $1000.0 as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Other Operating Expenses changed N/A year-over-year to $1000.0, compared with a TTM value of $1000.0 through Jun 2022, changed N/A, and an annual FY2016 reading of -$3.8 million, down 109.26% over the prior year.
  • Other Operating Expenses was $1000.0 for Q3 2021 at Arrowhead Pharmaceuticals, up from $281.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $4.5 million in Q1 2017 and bottomed at -$20.7 million in Q3 2017.
  • Average Other Operating Expenses over 3 years is -$4.1 million, with a median of $640.5 recorded in 2020.
  • Peak annual rise in Other Operating Expenses hit 20.57% in 2017, while the deepest fall reached 40.27% in 2017.
  • Year by year, Other Operating Expenses stood at -$20.7 million in 2017, then soared by 100.0% to $281.0 in 2020, then skyrocketed by 255.87% to $1000.0 in 2021.
  • Business Quant data shows Other Operating Expenses for ARWR at $1000.0 in Q3 2021, $281.0 in Q2 2020, and -$20.7 million in Q3 2017.